Chargement en cours...
The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone
The field of pharmacogenomics originally emerged in the 1950s from observations that a few rare individuals had unexpected, severe reactions to drugs(1). As recently as just six years ago, prominent views on the subject had largely remained unchanged, with authors from the FDA citing the purpose of...
Enregistré dans:
| Publié dans: | Clin Pharmacol Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830348/ https://ncbi.nlm.nih.gov/pubmed/26756170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.333 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|